Our previous studies confirmed that NEK2 is highly expressed in gastric cancer and is associated with patient prognosis, and analysis found that high expression of NEK2 indicates reduced immune cell infiltration in tissues, lower anti-tumor immune activity, and more sensitive to drugs targeting cell cycle and DNA replication pathways [18]. Here, NEK2 is linked to gastric cancer.